NCT06840613View on ClinicalTrials.gov

Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Gestational Diabetes Mellitus (GDM)
Interventions
OTHER

Myo-Inositol

"Intervention: Patients in this group will receive 2 capsules of Myo-Inositol (2000 mg each) along with 500 mg Glucophage three times a day.~Monitoring: Blood glucose levels will be measured at baseline and after treatment"

OTHER

Glucophage

"Intervention: Patients in this group will receive 500 mg Glucophage three times a day.~Monitoring: Blood glucose levels will be measured at baseline and after treatment."

All Listed Sponsors
lead

University of Health Sciences Lahore

OTHER